Reducing Opioid Mortality in Illinois (ROMI)
降低伊利诺伊州阿片类药物死亡率 (ROMI)
基本信息
- 批准号:10402783
- 负责人:
- 金额:$ 200.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-15 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccidentsAcuteAddressAttitudeBuprenorphineCaringCase ManagementChicagoColorCommunitiesCommunity OutreachControl GroupsCriminal JusticeDataDischarge PlanningsDiseaseEffectivenessEffectiveness of InterventionsEnrollmentEnsureEvidence based treatmentFaceFentanylFundingFutureGeographyHarm ReductionHealthHealth systemHeterogeneityHybridsIllinoisImprisonmentIncidenceIndividualInfrastructureInsuranceInterventionJailJusticeLeftMental Health ServicesMethadoneMethodsModelingNaloxoneNarcoticsNational Institute of Drug AbuseOpioidOutcomeOverdoseParticipantPatientsPersonsPharmaceutical PreparationsPhysiciansPositioning AttributePrisonsProviderPublic HealthRandomized Controlled TrialsRecoveryResearch DesignResearch PersonnelResistanceResourcesRiskRuralServicesSiteSocial WorkSocial statusStigmatizationSyringesSystemTestingTherapeuticTravelUniversitiesUrban CommunityUrban PopulationVisitWomanWorkbasebuprenorphine treatmentcare coordinationcare systemscommunity partnershipcommunity-level factorcultural competencedesigneffectiveness implementation designeffectiveness testingexperiencefollow-upgeographic barriergun homicideheroin overdosehigh riskhybrid type 1 studyimplementation barriersimplementation effortsimplementation evaluationimprovedmedication-assisted treatmentmembermenmortality riskopioid epidemicopioid mortalityopioid overdoseopioid useopioid use disorderopioid userpeerpragmatic trialprimary outcomerandomized trialrelapse riskrural arearural patientsrural settingsecondary outcomeservice engagementsubstance usesynthetic opioidtreatment armtreatment groupurban settingwaiver
项目摘要
PROJECT ABSTRACT
More than 2,700 Illinois residents died of opiate overdose in 2017—a number that surpassed the state’s
combined fatalities from road accidents and gun homicide. Individuals leaving jail and prison may be at highest
risk of fatal overdose and other drug-related harms. Severely vulnerable men and women face these risks at
precisely the moment they cross boundaries of fragmented criminal justice, social service, and public health
systems, and are thus most vulnerable to lost follow-up and disengagement from services, or to have other
basic needs left unattended. The challenge may be most acute for detainees who rapidly flow through jail
settings, where unpredictable departures hinder discharge planning and care coordination, and where justice
stakeholders may hold attitudes that stigmatize substance use or resistant to harm reduction interventions.
Individuals returning to Chicago communities of color are near relatively rich resources for both treatment and
harm reduction. Yet they must navigate epicenters of illicit narcotics distribution that feature particularly high
incidence of fatal overdose from heroin, fentanyl, and other synthetic opioids. Rural individuals in Southern
Illinois, may have long travel distances from any methadone facility or any DEA-waivered physician available to
prescribe buprenorphine. Rural patients also face geographic barriers to the provision of naloxone and SSPs.
Many harm reduction services have been designed and implemented to serve urban populations in traditional
centers of opioid use. The acceptability and cultural competence of such rural services remains understudied.
Our proposed multi-site ROMI trial (Reducing Opioid Mortality in Illinois) seeks to address this public health
challenge through improved supports and service linkages to medication-assisted treatment (MAT), naloxone
distribution, and syringe support services (SSPs) provided to justice-involved individuals living with opioid use
disorders. We seek to test whether a unified case management approach that includes peer recovery coaches
can improve treatment engagement and retention in five diverse urban and rural contexts that all experience
high rates of opioid disorders, overdose, and related harms.
We request funds to implement a five-site Randomized Controlled Trial, enrolling at least 1,000 individuals
living with OUD. The ROMI trial will be carried out using a hub-and-spoke model, with centralized long-
standing social services infrastructure at the Community Outreach Intervention Projects (COIP) hosted at the
University of Illinois at Chicago (UIC). COIP provides case management/transition of care services to justice-
involved opioid users, extending resources and technical assistance to less-populated rural areas hardest-hit
by the opioid epidemic. Using a hybrid type-one effectiveness implementation design, we propose a simple but
effective package of treatment and harm reduction interventions to reduce subsequent opioid use and related
harms in diverse contexts. Our pragmatic trial is thus well-positioned to test effectiveness while collecting
contextual data for implementation.
项目摘要
2017年,超过2700名伊利诺伊州居民死于阿片类药物过量--这个数字超过了该州
交通事故和持枪杀人案的综合死亡人数。离开监狱和监狱的人可能最多
有致命的过量用药和其他与药物有关的危害的风险。严重脆弱的男性和女性面临着这些风险
正是在他们跨越支离破碎的刑事司法、社会服务和公共卫生边界的那一刻
系统,因此最容易失去后续行动和脱离服务,或有其他
基本生活需求无人照管。对于迅速流经监狱的在押人员来说,这一挑战可能最为严峻
环境,不可预测的离境阻碍出院规划和护理协调,以及司法
利益相关者可能持有诋毁物质使用或抵制减少危害干预的态度。
返回芝加哥有色人种社区的个人接近相对丰富的治疗和治疗资源
减少危害。然而,他们必须在非法毒品分销的中心地带导航,这些中心的特点特别高
海洛因、芬太尼和其他合成阿片类药物致死过量的发生率。南方的农村人
伊利诺伊州,可能距离任何美沙酮设施或任何DEA豁免的医生有很长的旅行距离
开丁丙诺啡。农村患者在提供纳洛酮和SSP时也面临地理障碍。
已经设计和实施了许多减少危害的服务,以服务于传统的
阿片类药物使用中心。这种农村服务的可接受性和文化能力仍未得到充分研究。
我们提议的多点罗米试验(降低伊利诺伊州的阿片类药物死亡率)旨在解决这一公共卫生问题
通过改善对药物辅助治疗(MAT)、纳洛酮的支持和服务联系来应对挑战
向使用阿片类药物的司法人员提供分配和注射器支持服务(SSP
精神错乱。我们试图测试包括同伴康复教练在内的统一案例管理方法
可以在五个不同的城乡环境中提高治疗参与度和保留率,所有人都可以体验
阿片类药物紊乱、过量用药和相关危害的高比率。
我们要求资金来实施一项五个站点的随机对照试验,招募至少1,000人
和乌德住在一起。罗米审判将使用中心辐射式模式进行,集中的长轴
社区外展干预项目(COIP)的常备社会服务基础设施
伊利诺伊大学芝加哥分校(UIC)。COIP提供案件管理/向司法过渡的护理服务-
涉及阿片类药物使用者,将资源和技术援助扩展到受影响最严重的人口较少的农村地区
受阿片类药物泛滥的影响。使用混合类型1有效性实现设计,我们提出了一种简单但
有效的一揽子治疗和减少伤害干预措施,以减少随后的阿片类药物使用和相关
在不同的背景下造成的危害。因此,我们的务实试验处于有利地位,可以在收集
用于实施的上下文数据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HAROLD Alexander POLLACK其他文献
HAROLD Alexander POLLACK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HAROLD Alexander POLLACK', 18)}}的其他基金
Alternate Emergency Over Dose Response in Chicago
芝加哥的替代紧急剂量反应
- 批准号:
10618266 - 财政年份:2022
- 资助金额:
$ 200.55万 - 项目类别:
Alternate Emergency Over Dose Response in Chicago
芝加哥的替代紧急剂量反应
- 批准号:
10425012 - 财政年份:2022
- 资助金额:
$ 200.55万 - 项目类别:
Predictive Analytics Applied to Integrated Administrative Emergency Response Datasets in Chicago - Resubmission 01
预测分析应用于芝加哥综合行政应急响应数据集 - 重新提交 01
- 批准号:
10200643 - 财政年份:2019
- 资助金额:
$ 200.55万 - 项目类别:
Reducing Opioid Mortality in Illinois (ROMI)
降低伊利诺伊州阿片类药物死亡率 (ROMI)
- 批准号:
10671066 - 财政年份:2019
- 资助金额:
$ 200.55万 - 项目类别:
Predictive Analytics Applied to Integrated Administrative Emergency Response Datasets in Chicago - Resubmission 01
预测分析应用于芝加哥综合行政应急响应数据集 - 重新提交 01
- 批准号:
9981836 - 财政年份:2019
- 资助金额:
$ 200.55万 - 项目类别:
Reducing Opioid Mortality in Illinois (ROMI)
降低伊利诺伊州阿片类药物死亡率 (ROMI)
- 批准号:
9978033 - 财政年份:2019
- 资助金额:
$ 200.55万 - 项目类别:
Community network driven COVID-19 testing of vulnerable populations in the Central US
社区网络驱动的美国中部弱势群体 COVID-19 测试
- 批准号:
10274013 - 财政年份:2019
- 资助金额:
$ 200.55万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 200.55万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 200.55万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 200.55万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 200.55万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 200.55万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 200.55万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 200.55万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 200.55万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 200.55万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 200.55万 - 项目类别:
Operating Grants














{{item.name}}会员




